IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 200
EU - Europa 142
AS - Asia 92
AF - Africa 1
SA - Sud America 1
Totale 436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 200
DE - Germania 48
SG - Singapore 45
CN - Cina 35
CZ - Repubblica Ceca 30
IT - Italia 21
UA - Ucraina 12
RU - Federazione Russa 10
GB - Regno Unito 8
IN - India 7
HK - Hong Kong 4
FI - Finlandia 3
IE - Irlanda 2
PT - Portogallo 2
BE - Belgio 1
EC - Ecuador 1
FR - Francia 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PL - Polonia 1
SE - Svezia 1
Totale 436
Salva come PNG Salva come JPEG
Città #
Boardman 34
Fairfield 32
Singapore 27
Woodbridge 21
Houston 17
Shanghai 16
Brno 15
Olomouc 15
Ashburn 12
Jacksonville 10
Munich 10
Wilmington 10
Seattle 9
Cambridge 8
New York 8
Chandler 7
Mumbai 7
Beijing 6
Dearborn 5
Padova 5
Hong Kong 4
Nanjing 4
Princeton 4
Ann Arbor 3
Bergamo 3
Helsinki 3
Jinan 3
Des Moines 2
Dublin 2
Leipzig 2
Nürnberg 2
Palermo 2
Pavia 2
San Diego 2
San Francisco 2
Venice 2
Augusta 1
Bishkek 1
Bologna 1
Brescia 1
Brussels 1
Changsha 1
Guayaquil 1
Hangzhou 1
Hebei 1
Kunming 1
Lisbon 1
Los Angeles 1
Nanchang 1
Oslo 1
Philadelphia 1
Rabat 1
Riga 1
St Petersburg 1
Stockholm 1
Tianjin 1
Volzhsky 1
Walnut 1
Washington 1
Totale 339
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 141
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 130
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 14
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 10
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 8
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 8
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 7
Applying the ATN scheme in a memory clinic population: The ABIDE project 7
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 6
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 6
Clinical utility of FDG-PET for the clinical diagnosis in MCI 6
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 6
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 6
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 5
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 5
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 5
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 5
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 5
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 5
Medial temporal lobe atrophy and posterior atrophy scales normative values 5
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 5
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 5
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 5
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 4
AMYPAD Diagnostic and Patient Management Study: Rationale and design 4
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 4
Brain atrophy in Alzheimer's Disease and aging 4
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 4
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 4
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 4
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 4
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 4
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 4
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 4
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 4
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 4
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 4
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 4
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 3
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 3
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 2
Feasibility of a standard cognitive assessment in European academic memory clinics 2
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 2
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 2
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 2
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 2
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 2
Multitracer model for staging cortical amyloid deposition using PET imaging 2
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 1
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 1
Totale 489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202078 0 4 5 10 6 12 10 9 7 9 2 4
2020/202144 0 10 11 3 2 2 2 3 3 3 4 1
2021/202222 1 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 489